TopFunds

Vertex Pharmaceuticals Incorporated

NASDAQ: VRTX

Stock price

508.34 USD

(+169.96%) 5 years

Biotechnology

Insider Transactions

5Y price score: 234
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +169.96%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
08-sep.-26Award8,682--8,682van Grunsven Jasperofficer: EVP, CP and NPPOlink
28-aug.-26Award5,000--11,624Ambrose Kristenofficer: SVP & Chief Accounting Officerlink
21-jul.-26Award8,251--53,572Tatsis Ouraniaofficer: EVP, Chief Reg. & Quality Off.link
21-jul.-26Award8,251--66,512Sachdev Amitofficer: EVP Chief Patient & Ext Af Offlink
15-jul.-26Award100--15,772SACHS BRUCE Idirectorlink
15-jul.-26Award32--65Garber Alan Mdirectorlink
02-jul.-26Sale(1,500)525.0(787,485)45,321Tatsis Ouraniaofficer: EVP, Chief Reg. & Quality Off.link
02-jul.-26Sale(1,541)519.0(799,779)11,001McKechnie Duncanofficer: EVP, Chief Commercial Officerlink
01-jul.-26Sale(828)502.7(416,244)19,131Liu Joyofficer: EVP and Chief Legal Officerlink
26-jun.-26Sale(596)482.5(287,570)15,337Bozic Carmenofficer: EVP and CMOlink

374.1

52-week range

560.2

508.34

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

2.9 %

Dividend Yield TTM

-

Market cap $

$ 129,019

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

29.6

Price / Book TTM

6.4

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

0

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

31.3 %

170 %

448.3 %

Free cash flow per share growth

10.6 %

8.9 %

827.3 %

Earnings per share growth

8 %

48.9 %

763.2 %

Analyst ratings

Price Target Low

350

Price Target High

665

Price Target Median

577.5

Buy

48

Hold

7

Sell

1

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
(2.3)
(0.5)
1
8.1
4.5
10.3
9
12.8
13.9
(2.1)
15.3
-
12.1
15.3
19.5
24.7
31.4
32.2
02FCF per share
(1.7)
0.7
2.3
4.5
5.7
11.4
9.3
15.1
12.6
(3.1)
12.4
-
13.4
17.1
21.7
27.7
35.3
34.9
03Dividends per share
Help
Adjusted for splitsLearn more
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
05Revenue
$ 1,032
$ 1,702
$ 2,489
$ 3,048
$ 4,163
$ 6,206
$ 7,574
$ 8,931
$ 9,869
$ 11,020
$ 12,075
27.9%
$ 15,441
$ 19,746
$ 25,252
$ 32,292
$ 41,295
$ 42,534
06ㅤ% Change
-
64.9%
46.2%
22.5%
36.6%
49.1%
22.1%
17.9%
10.5%
11.7%
9.6%
27.9%
27.9%
27.9%
27.9%
27.9%
27.9%
27.9%
07Net Income
(558.1)
(112.1)
263.5
2,097
1,177
2,712
2,342
3,322
3,620
(535.6)
3,953
-
3,136
4,010
5,128
6,558
8,386
8,638
08ㅤ% Margin
(54.1)%
(6.6)%
10.6%
68.8%
28.3%
43.7%
30.9%
37.2%
36.7%
(4.9)%
32.7%
20.3% A
20.3%
20.3%
20.3%
20.3%
20.3%
20.3%
09CFO
(365.4)
236.1
844.9
1,270
1,569
3,254
2,644
4,130
3,537
(492.6)
3,631
-
4,026
5,149
6,584
8,420
10,768
11,091
10ㅤ% Of revenue
(35.4)%
13.9%
34%
41.7%
37.7%
52.4%
34.9%
46.2%
35.8%
(4.5)%
30.1%
26.1% A
26.1%
26.1%
26.1%
26.1%
26.1%
26.1%
11CAPEX
(45.3)
(56.6)
(259.4)
(95.5)
(75.5)
(259.8)
(235)
(204.7)
(258.4)
(297.7)
(437.6)
25.5%
(549)
(688.8)
(864.1)
(1,084)
(1,360)
(1,706)
12ㅤ% Change
-
24.9%
358.6%
(63.2)%
(21)%
244.3%
(9.6)%
(12.9)%
26.2%
15.2%
47%
25.5% A
25.5%
25.5%
25.5%
25.5%
25.5%
25.5%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
(410.7)
179.5
585.5
1,175
1,494
2,994
2,409
3,925
3,279
(790.3)
3,194
-
3,477
4,460
5,720
7,336
9,408
9,384
14Total assets
2,497
2,894
3,546
6,246
8,319
11,752
13,433
18,151
22,730
22,533
26,143
26.5%
33,063
41,816
52,885
66,884
84,589
106,981
15ㅤ% Change
-
15.9%
22.5%
76.1%
33.2%
41.3%
14.3%
35.1%
25.2%
(0.9)%
16%
26.5%
26.5%
26.5%
26.5%
26.5%
26.5%
26.5%
16Total liabilities
1,405
1,559
1,504
1,811
2,233
3,065
3,333
4,238
5,150
6,124
7,477
18.2%
9,456
11,960
15,125
19,129
24,193
30,597
17ㅤ% Of assets
56.3%
53.9%
42.4%
29%
26.9%
26.1%
24.8%
23.4%
22.7%
27.2%
28.6%
28.6% A
28.6%
28.6%
28.6%
28.6%
28.6%
28.6%
18Shareholders Equity
1,092
1,335
2,042
4,435
6,085
8,687
10,100
13,913
17,580
16,410
18,666
32.8%
23,607
29,856
37,759
47,755
60,396
76,384
19Net Debt
111.5
(343.2)
(1,059)
(2,063)
(2,448)
(5,056)
(5,828)
(9,604)
(9,561)
(2,820)
(1,205)
-
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
241,312
244,685
253,225
259,185
260,673
263,396
259,900
259,100
260,500
257,900
258,000
0.7%
259,731
261,474
263,228
264,994
266,772
268,562
21ㅤ% Change
-
1.4%
3.5%
2.4%
0.6%
1%
(1.3)%
(0.3)%
0.5%
(1)%
-
0.7%
0.7%
0.7%
0.7%
0.7%
0.7%
0.7%
22ROA
(22.4)%
(3.9)%
7.4%
33.6%
14.2%
23.1%
17.4%
18.3%
15.9%
(2.4)%
15.1%
-
9.5%
9.6%
9.7%
9.8%
9.9%
8.1%
23ROE
(51.1)%
(8.4)%
12.9%
47.3%
19.3%
31.2%
23.2%
23.9%
20.6%
(3.3)%
21.2%
-
13.3%
13.4%
13.6%
13.7%
13.9%
11.3%
24Interest coverage
(5.6)
0.1
1.8
18.6
20.5
49.1
45.2
78.6
86.9
(7.6)
357.9
-
-
-
-
-
-
-
25Dividend Yield
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
26P/E Ratio
(54.2)
(160.2)
141.4
20.1
47.8
22.6
24.2
22.3
29
(193.6)
29.3
-
-
-
-
-
-
-
27Stock price range
98-141
72-123
75-166
146-193
164-224
200-303
177-241
221-321
283-411
393-517
367-514
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
30,305
17,945
37,294
42,139
56,211
61,411
56,591
73,957
104,856
103,695
115,924
14.4%
106,444
116,968
128,544
141,278
155,285
-
29FCF Yield
(1.4)%
1%
1.6%
2.8%
2.7%
4.9%
4.3%
5.3%
3.1%
(0.8)%
2.8%
-
3.3%
3.8%
4.5%
5.2%
6.1%
-
30Average stock price
120
97.7
120.5
169.2
193.8
251.4
209.2
271.5
347
454.8
440.2
13.9%
409.8
447.3
488.3
533.1
582.1
-
31 CEO
RK
Reshma Kewalramani